Celanese, First Hawaiian, Peloton Interactive, Qorvo and Zip Recruiter were included among the Thursday afternoon analyst upgrades and downgrades.
Wednesday's top analyst upgrades and downgrades included Clorox, ConocoPhillips, Exxon Mobil, Ferrari, Kraft Heinz, Nvidia and Under Armour.
Revolution Medicines entered the market with a bang on Thursday. Although the company only priced shares are $17 apiece, the stock actually entered the market closer to $28.
We screened our 24/7 Wall St. research database and found five stocks trading under the $10 level that could provide investors with some solid upside potential.
The stock market is down Wednesday, with the Dow Jones Industrial Average down 0.04%, the Nasdaq down 0.04% and the S&P 500 down 0.14%. Today’s winners are a clinical trial management firm that is...
Source: Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning.Amgen Inc. (NASDAQ: AMGN) Raised to Neutral with...
Stocks got off on a positive note this morning, but resisted the temptation to climb based on a positive reading of the leading econonmic indicators and higher estimates of US GDP growth in the...
Stocks opened lower this morning and stayed lower for nearly the entire first half of the day, with buyers most likely waiting to see what would happen with Italian bond rates. The bonds ended the...
Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week.  Merck plans to emerge next year and into the next decade leaner and more...
(AGE) A.G.Edwards gets an $89.50 buyout from Wachovia (WB) in cash and stock.(AGIX) AtheroGenics announces business plan to focus on advancing AGI-1067 in diabetes.(ASML) ASML will return 960 million...
Daktronics, Inc. (Nasdaq: DAKT) 17.8% LOWER; now estimates that net sales for the fourth quarter of fiscal 2007 will be in the range of $101 million to $105 million, with earnings in the range of...